汇宇制药：8月28日召开第二届董事会独立董事专门会议第四次会议

Group 1 - The core point of the article is that Huiyu Pharmaceutical announced an increase in the expected amount of daily related transactions for the year 2025 during a board meeting held on August 28, 2025 [1] - For the year 2024, Huiyu Pharmaceutical's revenue composition is 99.18% from pharmaceuticals and 0.82% from other businesses [1] - As of the report, Huiyu Pharmaceutical has a market capitalization of 10.5 billion yuan [1] Group 2 - The company held its fourth independent director meeting to discuss important financial matters [1] - The meeting included the review of documents related to the increase in expected daily related transactions [1]